Navigation Links
UCSF Tops Public Institutions in NIH Funding, Ranks Second Overall
Date:4/7/2010

UCSF received more research funds from the National Institutes of Health than any other public institution in 2009, and received the second largest amount of all institutions nationwide, according to new figures released by the NIH. The UCSF School of Pharmacy, specifically, ranked first in its field in NIH support for the 30th consecutive year.

(Vocus) April 7, 2010 -- UCSF received more research funds from the National Institutes of Health than any other public institution in 2009, and received the second largest amount of all institutions nationwide, according to new figures released by the NIH. The UCSF School of Pharmacy, specifically, ranked first in its field in NIH support for the 30th consecutive year.

The federal funding plays a vital role in fueling UCSF’s biomedical research enterprise, in which scientists study the genetic, molecular and cellular basis of diseases and carry out epidemiological and clinical-research studies, working to develop treatments and cures. This research has led to UCSF scientists being among the most prolific publishers of scientific discoveries worldwide.

"Federal funding drives biomedical sciences at UCSF and allows for important discoveries that enable improvements in health that impact not only our nation, but humanity worldwide," says UCSF Chancellor Susan Desmond-Hellmann, MD, MPH.

UCSF received more than $463 million for research and training grants, fellowships and other awards in 2009. In 2008, UCSF also ranked second in the nation, at $444 million. The figures do not include NIH research contracts or funding through the American Recovery and Reinvestment Act, both of which the NIH tallies separately.

The UCSF School of Pharmacy received nearly $19 million in NIH funding in 2009, while the UCSF School of Dentistry, School of Medicine and School of Nursing all ranked second nationally in their fields. The School of Dentistry received more than $15.5 million in NIH research support; the School of Medicine $409 million; and the School of Nursing, $8.8 million.

The UCSF School of Medicine also received another $8.7 million in overall medical grants, which are listed separately by the NIH, for a total of $417.7 million.

UCSF overall and each of its schools have ranked within the top four institutions and related schools nationally in total NIH funding for more than a decade. Its schools of Dentistry, Nursing and Pharmacy have ranked first or second for several decades.

These successes occur against a backdrop of increasing competition for NIH grants, which are awarded to only a fraction of the scientists who apply for funding, says Desmond-Hellmann.

"In light of the extremely challenging funding environment, this broad-based support of UCSF research is testament to the caliber of scientific discovery occurring in each of our schools," she said.

The federal support has enabled UCSF scientists to pursue scientific questions that have led to several Nobel Prizes in Physiology or Medicine. Last year, a UCSF scientist was honored for co-discovering an enzyme known as telomerase (tel-AH-mer-AZE) that is now a target for treating age-related diseases and cancer and for measuring the impact of stress on cells. In 1997, a UCSF scientist was honored for discovering a protein known as a prion (PREE-on) that causes rare, neurodegenerative diseases, a finding that has informed scientists' understanding of such brain diseases as Alzheimer's and Parkinson’s disease.

In 1989, two other UCSF scientists received the Nobel Prize for co-discovering proto-oncogenes, normal genes that have the potential to convert to cancer genes. The discovery transformed the way scientists look at cancer and has led to new strategies for detection and treatment of the disease.

The federal funding also supports the local and regional economy, Desmond-Hellmann said, via the scientists’ spending on materials, instruments and technical staff for their laboratories; the patents and scientific advances the research generates; and the related industries, such as biotechnology, that it fuels.

According to data posted by the NIH (http://report.nih.gov/award/trends/findorg.cfm), the top five recipients of its FY 2009 research funding were as follows.

Overall institutions:
1)   Johns Hopkins University ($603.4 million)
2)   UCSF ($463.3 million)
3)   University of Pennsylvania ($454.9 million)
4)   University of Michigan, Ann Arbor ($454.2 million).
5)   University of Pittsburgh ($418.0 million)

Schools of Dentistry:
1)   University of Pennsylvania ($19.4 million)
2)   UCSF ($15.5 million)
3)   University of Michigan, Ann Arbor ($12.6 million)
4)   University of Florida ($11.1 million)
5)   Boston University Medical Campus ($10.2 million)

Schools of Medicine:
1)   Johns Hopkins University ($434.9 million)
2)   UCSF ($409.0 million, plus $8.7 million in "overall medical grants")
3)   University of Pennsylvania ($368.8 million)
4)   Washington University ($357.8 million)
5)   Yale University ($322.7 million).

Schools of Nursing:
1)   University of Pennsylvania ($10.9 million)
2)   UCSF ($8.8 million)
3)   University of Washington ($8.5 million)
4)   Johns Hopkins University ($7.0 million)
5)   University of Pittsburgh ($6.8 million).

Schools of Pharmacy:
1)   UCSF ($18.9 million)
2)   University of Kansas, Lawrence ($17.8 million)
3)   University of N. Carolina, Chapel Hill ($16.8 million)
4)   University of Utah ($10.7 million)
5)   University of Illinois, Chicago ($10.2 million).

UCSF is a leading university dedicated to promoting health worldwide through advanced biomedical research, graduate-level education in the life sciences and health professions, and excellence in patient care. For more information, visit www.ucsf.edu.

Contact:
Kristen Bole
(415) 476-2557
Web: www.ucsf.edu

# # #

Read the full story at http://www.prweb.com/releases/UCSF_NIH_Research/Grant_Award/prweb3843114.htm.


'/>"/>
Source: PRWeb
Copyright©2010 Vocus, Inc.
All rights reserved  

Related medicine news :

1. Concord Medical Services Holdings Limited Announces Pricing of Initial Public Offering on the New York Stock Exchange
2. Centegra Expands H1N1 Vaccines to General Public
3. Traceability Institute Comments on Improving Food Safety System for Consumers at Food and Drug Administration (FDA) and Food Safety and Inspection Service (FSIS) Joint Public Meeting
4. Pelosi: Lifting the Ban on Federal Funding for Syringe Exchange is a Victory for Science and for Public Health
5. TFAH Praises Presidents Budget for Consistent Commitment to Public Health and Prevention
6. Public Health and Environmental Groups Support Stronger National Air Quality Standards for Ozone
7. President Obama Highlights Bipartisan Policy Center Health Care Reform Plan in Remarks to House Republicans
8. Amilpar - Relevant Fact - Public Offer Result
9. Integrating private insurance with public health would improve US health care -- study
10. TouchSurfaces.Org Launches Public Health Information Site for Advanced Disinfectant Solutions for Use Around Children and Pets
11. Public Health in Focus at International Conference
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
UCSF Tops Public Institutions in NIH Funding, Ranks Second Overall
(Date:1/18/2017)... ... January 18, 2017 , ... Michael ... new website for its Center for Biosimilars, announced Michael J. Hennessy Associates, Inc. ... in the field of biosimilars through thought leader interaction in, live video and ...
(Date:1/18/2017)... ... January 18, 2017 , ... During ... disease to enamel erosion, and those dental problems can increase the risk of ... many pregnant women are failing to get the dental care they need. Agoura ...
(Date:1/17/2017)... ... January 17, 2017 , ... Anesthesia Progress – Everyone wants less ... best drug option for each patient. Dentists have several general anesthesia alternatives and finding ... Researchers from the Tokyo Dental College in Tokyo, Japan wanted to find out which ...
(Date:1/17/2017)... ... January 17, 2017 , ... For breast cancer clinicians and researchers who ... who desire a more intimate review and analysis of its highlights, a novel half-day, ... being offered by Imedex on February 4, 2017 in Chicago. Chaired by Kathy S. ...
(Date:1/17/2017)... (PRWEB) , ... January 17, 2017 , ... SunView Software’s ... Award for Innovation of the Year. , Each year, Pink Elephant recognizes ... an innovative approach to address a specific business problem or opportunity. The award highlights ...
Breaking Medicine News(10 mins):
(Date:1/18/2017)... SAN DIEGO , Jan. 18, 2017 /PRNewswire/ ... manufacturing solutions for cell and advanced therapies , ... the French biopharmaceutical company developing "tumor starvation" treatments ... unmet medical needs. Under the agreement, Invetech will ... products based on Erytech,s proprietary ERYCAPS technology platform, ...
(Date:1/18/2017)... -- After the recent election cycle, it is ... both for medical and recreational purposes are shifting. The evidence ... use of cannabis, but the focus is coming from both ... the North American legal cannabis market posted $6.7 billion in ... research projects sales will grow at a compound annual growth ...
(Date:1/17/2017)... Jan. 17, 2017 North America Insulin Delivery ... report, "North America Insulin Delivery Market Outlook to 2022", ... Delivery market. The report provides value, in millions of ... within market segments - Insulin Pens, Insulin Pumps, Insulin ... also provides company shares and distribution shares data for ...
Breaking Medicine Technology: